This can lead to several effects that promote weight loss: Increased Insulin Release: GLP-1 helps the body release more insulin, which lowers blood sugar levels and signals to the body to store excess glucose as energy instead of fat
They usually diminish as the body adjusts, but in some cases, they can be persistent and severe enough to require discontinuation of the medication
Clinical services are provided by OpenLoop Healthcare Partners, PC and other networks who determine eligibility for Wegovy based on medical history and assessment responses
The longer answer requires understanding what the April 30 notice actually says, what the June 30, 2026 comment deadline means, and the practical difference between the two compounding pathways
What we found in general is of course everybody ate less, about 20% less, but number one, the calorie distribution and protein intake was suboptimal